227 related articles for article (PubMed ID: 2482974)
1. The neuraminidase of influenza virus.
Air GM; Laver WG
Proteins; 1989; 6(4):341-56. PubMed ID: 2482974
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.
Colman PM; Laver WG; Varghese JN; Baker AT; Tulloch PA; Air GM; Webster RG
Nature; 1987 Mar 26-Apr 1; 326(6111):358-63. PubMed ID: 2436051
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
Nuss JM; Whitaker PB; Air GM
Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
[TBL] [Abstract][Full Text] [Related]
4. Influenza virus neuraminidase: structure, antibodies, and inhibitors.
Colman PM
Protein Sci; 1994 Oct; 3(10):1687-96. PubMed ID: 7849585
[TBL] [Abstract][Full Text] [Related]
5. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
Nuss JM; Air GM
J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
[TBL] [Abstract][Full Text] [Related]
6. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
Varghese JN; Epa VC; Colman PM
Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
[TBL] [Abstract][Full Text] [Related]
9. Electron and X-ray diffraction studies of influenza neuraminidase complexed with monoclonal antibodies.
Tulloch PA; Colman PM; Davis PC; Laver WG; Webster RG; Air GM
J Mol Biol; 1986 Jul; 190(2):215-25. PubMed ID: 3795268
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
Air GM; Laver WG; Webster RG
J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
12. Structure of the catalytic and antigenic sites in influenza virus neuraminidase.
Colman PM; Varghese JN; Laver WG
Nature; 1983 May 5-11; 303(5912):41-4. PubMed ID: 6188957
[TBL] [Abstract][Full Text] [Related]
13. Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.
Smith BJ; Huyton T; Joosten RP; McKimm-Breschkin JL; Zhang JG; Luo CS; Lou MZ; Labrou NE; Garrett TP
Acta Crystallogr D Biol Crystallogr; 2006 Sep; 62(Pt 9):947-52. PubMed ID: 16929094
[TBL] [Abstract][Full Text] [Related]
14. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
15. Crystals of antibodies complexed with influenza virus neuraminidase show isosteric binding of antibody to wild-type and variant antigens.
Laver WG; Webster RG; Colman PM
Virology; 1987 Jan; 156(1):181-4. PubMed ID: 3811232
[TBL] [Abstract][Full Text] [Related]
16. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
[TBL] [Abstract][Full Text] [Related]
17. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
18. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
[TBL] [Abstract][Full Text] [Related]
19. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses.
Yang P; Bansal A; Liu C; Air GM
Virology; 1997 Mar; 229(1):155-65. PubMed ID: 9123857
[TBL] [Abstract][Full Text] [Related]
20. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Air GM; Luo M
Proteins; 1995 Oct; 23(2):264-77. PubMed ID: 8592707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
